Brief: Integral Diagnostics Sees FY23 Replacement And Growth Capex Between A$30Mln To A$40Mln
Nov 4 (Reuters) - Integral Diagnostics Ltd IDX.AX :
* FY23 REPLACEMENT AND GROWTH CAPEX IS EXPECTED TO BE
BETWEEN
A$30MLN TO A$40MLN
Source text for Eikon: ID:nASX69w8HT
Further company coverage: IDX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Integral Diagnostics
See all newsBrief: Integral Diagnostics Announces Preliminary FY26 Results And Appointment Of New CFO
Brief: Integral Diagnostics Responds To Media Reporting In WA
Australia's Integral Diagnostics loses most in 1-1/2 years, denies allegations on inappropriate billing
Jardine's $2.4 bln radiology pivot scans well
Jardine's $2.4 bln radiology pivot scans well